DR. ANDREW THOMAS CATANZARO, MD
Osteopathic Medicine in Washington, DC
License number
DC MD300619
Category
Osteopathic Medicine
Type
Infectious Disease
Address
Address
2
1900 Mass Ave SE, Washington, DC 20003
7910 Carroll Ave SUITE 280, Silver Spring, MD 20912
7910 Carroll Ave SUITE 280, Silver Spring, MD 20912
Phone
(202) 548-6500
(202) 891-6610
(202) 355-7601 (Fax)
(202) 891-6610
(202) 355-7601 (Fax)
Personal information
See more information about ANDREW THOMAS CATANZARO at radaris.comName
Address
Phone
10402 Gatewood Ter, Silver Spring, MD 20903
1733 Kilbourne Pl NW, Washington, DC 20010
712 Butternut St NW, Washington, DC 20012
Professional information
Dr. Andrew T Catanzaro, Washington DC - MD (Doctor of Medicine)
Specialties:
Infectious Disease Medicine
Address:
1900 Massachusetts Ave SE SUITE 29, Washington 20003
(202) 548-6500 (Phone), (202) 548-7526 (Fax)
850 Delaware Ave SW, Washington 20024
(202) 548-4520 (Phone), (202) 484-0209 (Fax)
UNITY HEALTH CARE
1900 Massachusetts Ave SE SUITE 1242, Washington 20003
(202) 548-6500 (Phone), (202) 698-8040 (Fax)
WASHINGTON ADVENTIST HOSPITAL
7600 Carroll Ave, Takoma Park 20912
(301) 891-5393 (Phone), (301) 891-6184 (Fax)
(202) 548-6500 (Phone), (202) 548-7526 (Fax)
850 Delaware Ave SW, Washington 20024
(202) 548-4520 (Phone), (202) 484-0209 (Fax)
UNITY HEALTH CARE
1900 Massachusetts Ave SE SUITE 1242, Washington 20003
(202) 548-6500 (Phone), (202) 698-8040 (Fax)
WASHINGTON ADVENTIST HOSPITAL
7600 Carroll Ave, Takoma Park 20912
(301) 891-5393 (Phone), (301) 891-6184 (Fax)
Certifications:
Infectious Disease, 2008, Internal Medicine, 1995
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1900 Massachusetts Ave SE SUITE 29, Washington 20003
850 Delaware Ave SW, Washington 20024
WASHINGTON ADVENTIST HOSPITAL
7600 Carroll Ave, Takoma Park 20912
UNITY HEALTH CARE
1900 Massachusetts Ave SE SUITE 1242, Washington 20003
MedStar Washington Hospital Center
110 Irving St North #West, Washington 20010
United Medical Center
1310 Southern Ave South #East, Washington 20032
850 Delaware Ave SW, Washington 20024
WASHINGTON ADVENTIST HOSPITAL
7600 Carroll Ave, Takoma Park 20912
UNITY HEALTH CARE
1900 Massachusetts Ave SE SUITE 1242, Washington 20003
MedStar Washington Hospital Center
110 Irving St North #West, Washington 20010
United Medical Center
1310 Southern Ave South #East, Washington 20032
Education:
Medical School
Virginia Commonwealth University / Medical College of Virginia School of Medicine
Graduated: 1992
Virginia Commonwealth University / Medical College of Virginia School of Medicine
Graduated: 1992
Principal Investigator At Unity Health Care
Location:
Washington D.C. Metro Area
Industry:
Medical Practice
Andrew Thomas Catanzaro, Takoma Park MD
Specialties:
Infectious Disease Specialist
Address:
7600 Carroll Ave, Takoma Park, MD 20912
1900 Massachusetts Ave Se, Washington, DC 20003
1900 Massachusetts Ave Se, Washington, DC 20003
Education:
Doctor of Medicine*
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine*, American Board of Internal Medicine Sub-certificate in Infectious Disease (Internal Medicine)*
Vaccines And Methods For Prevention And Treatment Of Drug-Resistant Hiv-1 And Hepatitis B Virus
US Patent:
2009031, Dec 24, 2009
Filed:
Feb 22, 2006
Appl. No.:
11/816704
Inventors:
Andrew Catanzaro - Washington DC, US
Robert Yarchoan - Bethesda MD, US
Jay A. Berzofsky - Bethesda MD, US
Takahiro Okazaki - Kanagawa, JP
Samuel Broder - Bethesda MD, US
Robert Yarchoan - Bethesda MD, US
Jay A. Berzofsky - Bethesda MD, US
Takahiro Okazaki - Kanagawa, JP
Samuel Broder - Bethesda MD, US
Assignee:
THE GOV'T OF USOA as represented by the SECRETARY OF THE DEPT OF HHS - Rockville MD
International Classification:
A61K 39/21, A61K 39/12, A61K 39/29, C12N 5/00, C07K 7/06, C12N 7/06, A61P 31/18, A61P 31/12, A61P 31/14
US Classification:
4241881, 4241861, 4241891, 435377, 530328, 435238
Abstract:
The present invention provides methods for lowering a viral load of a virus resistant to an antiviral drug by inducing cytotoxic T lymphocytes (CTL) to recognize a predetermined mutated epitope within a viral protein of the drug-resistant virus. CTLs are induced by immunizing a host with a peptide comprising the predetermined mutation. The immunostimulating peptide may be further improved by epitope-enhancement for inducing specific CTLs. The antiviral protection against drug-resistant virus shown by compositions of the present invention and mediated by human HLA-restricted CTL has not been previously achieved.